Cargando…
Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systematic review and meta-analysis
BACKGROUND: Aspirin has been revealed to probably decrease the risk of cholangiocarcinoma (CCC), which, nevertheless, is of controversy. To this end, a systematic review and meta-analysis was performed to investigate the above-described association. METHODS: We thoroughly searched PubMed, EMBASE, an...
Autores principales: | Xiong, Jianping, Xu, Weiyu, Bian, Jin, Huang, Hanchun, Bai, Yi, Xu, Yiyao, Lu, Xin, Zhao, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173493/ https://www.ncbi.nlm.nih.gov/pubmed/30323665 http://dx.doi.org/10.2147/CMAR.S173197 |
Ejemplares similares
-
Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma
por: Xiong, Jianping, et al.
Publicado: (2017) -
Metabolic syndrome and the risk of cholangiocarcinoma: a hospital-based case–control study in China
por: Xiong, Jianping, et al.
Publicado: (2018) -
Preoperative neutrophil–lymphocyte and platelet–lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma
por: Huang, Hanchun, et al.
Publicado: (2019) -
Alcoholic liver disease and risk of cholangiocarcinoma: a systematic review and meta-analysis
por: Xiong, Jianping, et al.
Publicado: (2018) -
Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: a meta-analysis
por: Xiong, Jianping, et al.
Publicado: (2017)